Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grayson W Stowell

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section C, Crystal Structure Communications|August 3, 2002
Polymorphic forms of cilostazolLinda B Whittall, Robert R Whittle, Grayson W Stowell
Journal of Pharmaceutical Sciences|November 16, 2002
Thermally-prepared polymorphic forms of cilostazolGrayson W Stowell, Robert J Behme, Stacy M Denton, et al.
Pharmaceutical Research|September 16, 2022
Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis TreatmentIan E Stewart, Phillip G Durham, Jacob M Sittenauer, et al.
Molecular Cancer Therapeutics|September 16, 2004
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic diseaseSukhdev S Brar, Claude Grigg, Kimberly S Wilson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section C, Crystal Structure Communications|August 3, 2002
Polymorphic forms of cilostazolLinda B Whittall, Robert R Whittle, Grayson W Stowell
Journal of Pharmaceutical Sciences|November 16, 2002
Thermally-prepared polymorphic forms of cilostazolGrayson W Stowell, Robert J Behme, Stacy M Denton, et al.
Pharmaceutical Research|September 16, 2022
Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis TreatmentIan E Stewart, Phillip G Durham, Jacob M Sittenauer, et al.
Molecular Cancer Therapeutics|September 16, 2004
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic diseaseSukhdev S Brar, Claude Grigg, Kimberly S Wilson, et al.
Pageof 1